Institutional investors purchased a net $1.7 million shares of NNVC during the quarter ended March 2015. This may signal that the smart money is gaining interest in this company as the 6.90% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SUSQUEHANNA FINANCIAL GROUP LLLP Bought 222.3 Thousand shares of NanoViricides Inc
RENAISSANCE TECHNOLOGIES LLC Bought 188.4 Thousand shares of NanoViricides Inc
MILLENNIUM MANAGEMENT LLC Bought 120.5 Thousand shares of NanoViricides Inc